45:54
How Much is Right for You: The Science of CBD Dosing
-
Video
-
Audio
-
Table of contents
-
Video
-
Audio
- Description
- Transcript
- Discussion
About the talk
One of the challenges in the emerging CBD market is the lack of robust clinical research that can be used to guide dosing guidelines. This is especially problematic in people with comorbidities or on other medications who would like to explore taking these products medicinally too. Even so, crowdsourcing the anecdotal data has allowed companies to review by developing a functional measure of how much CBD is needed for different conditions. This system, albeit lacking in strong foundations in clinical trials, in some ways is good enough. But when it comes to a product we want to promote as medication, we have a responsibility to produce real data from which to work off of.
00:40 Biochemistry dosing
04:15 Anticonvulsant
08:05 Tetrahydrocannabinol
12:20 Drug interaction
15:25 Anticoagulant
19:00 Over-the-counter drug
23:35 Checking with the pharmacist
26:40 Signal transduction
29:55 The lack of knowledge
34:10 Capturing data
39:30 The absorption rates
About speakers
Dr. Cohin Kakar comes from a background in the pharmaceutical industry, working with various Fortune 150 companies in roles ranging from clinical trial management to global medical affairs for over 10 years. Most notably, Dr. Kakar served on the medical launch teams for some of the biggest commercial drugs globally, with a specialty in inflammation and immunology. Lastly, Dr. Kakar is a published author in Oncology and Cannabis with more publications underway.
View the profileAs a pharmacist in a geriatric clinic, my mission is to provide senior community members with the care, medication management and support they need to achieve the highest quality of life – while staying independent as long as possible.
View the profileI am a Physician Assistant with almost 5 years of experience in pain management. I saw first hand how CBD can help patients with chronic pain and that sparked my interest. I started a Wellness clinic specializing in Non-Opioid Pain Therapies and then started my own CBD line. It is important that my patients are able to obtain legitimate THC free products due to a lot of my patients being on pain medicine contracts. I obtained the registered trademark "Medically Assisted CBD" to bring more legitimacy to the CBD and show patients they have a trusted medical provider in this space.
View the profileDaniel Tobon founded Starchup, Inc. Currently, he occupies the position of Chief Operating Officer & Director at iVIK Holdings Ltd. and Secretary & Director at Pinehurst Capital I, Inc. He is also on the board of Huntington Valley Ventures, Inc. In his past career Daniel Tobon occupied the position of Chief Executive & Operating Officer of Starchup, Inc. and Chief Executive Officer of Franklin Labs LLC. Mr. Tobon received a doctorate from The University of Chicago Law School and an undergraduate degree from the University of Illinois At Urbana–Champaign.
View the profileGood morning, everyone. My name is Cohen kid car, and you're attending the panel on the science of CBD dosing, very excited to moderate and be a part of this panel, as many of, you know, in this industry. Dosing is one of the biggest challenges when you look at different dosage forms, when you look at absorption rates, it's it's a science in itself and really diagnosing the right uses some symptoms that products can be effective in and dosing those up appropriately. My training is I'm actually a pharmacist myself. So this is a topic. I'm very passionate about the co-founder of our company
called The Inn. At those group, we've launched two different cannabinoid lines, one being site ocx in the medical space and then title sport which is in the sports recovery space. I'm doing with the awesome panel who can definitely help us answer these questions around dosing, I'll start by introducing them first. Were joined by Dan Tobin who is an attorney and CEO of Isaac holding an Cannabinoid company. He has extensive experience in the clinical trials and testing of cannabinoid products and he's also a US Army veteran. We're also joined by Charlie Permanente
pain management. He's has a master's degree of Science and Physiology and a physician assistant studies in a master's in public health. He's a CEO. And founder of restorative, cbdn is a co-author on a peer-reviewed article reviewing current literature about CBD in pain. And finally, we have doctor in the jeep has children. She graduated from Wayne State
Buy this talk
Full access to all event's session replays
Interested in topic “Cannabis & CBD”?
You might be interested in videos from this event
Buy this video
Conference Cast
With ConferenceCast.tv, you get access to our library of the world's best conference talks.
